Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1963 4
1964 14
1965 23
1966 17
1967 17
1968 35
1969 51
1970 63
1971 62
1972 91
1973 93
1974 84
1975 94
1976 80
1977 98
1978 91
1979 92
1980 97
1981 73
1982 88
1983 63
1984 88
1985 92
1986 88
1987 102
1988 88
1989 88
1990 136
1991 104
1992 87
1993 76
1994 91
1995 112
1996 52
1997 57
1998 65
1999 49
2000 43
2001 60
2002 41
2003 52
2004 36
2005 43
2006 46
2007 57
2008 38
2009 28
2010 44
2011 38
2012 38
2013 42
2014 40
2015 48
2016 51
2017 50
2018 36
2019 59
2020 61
2021 45
Text availability
Article attribute
Article type
Publication date

Search Results

3,608 results
Results by year
Filters applied: . Clear all
Page 1
Cholestyramine.
Thompson WG. Thompson WG. Can Med Assoc J. 1971 Feb 20;104(4):305-9. Can Med Assoc J. 1971. PMID: 5544698 Free PMC article. Review. No abstract available.
Cholestyramine.
[No authors listed] [No authors listed] Lancet. 1968 Aug 24;2(7565):444. Lancet. 1968. PMID: 4174167 No abstract available.
Cholestyramine decreases apparent total tract macronutrient digestibility and alters fecal characteristics and metabolites of healthy adult dogs.
Alexander C, Guard BC, Suchodolski JS, Swanson KS. Alexander C, et al. J Anim Sci. 2019 Mar 1;97(3):1020-1026. doi: 10.1093/jas/sky437. J Anim Sci. 2019. PMID: 30423121 Free PMC article.
Dogs fed cholestyramine had greater (P < 0.01) as-is and dry fecal output than controls. ...Future studies are required to explore the effects of cholestyramine on dogs with gastrointestinal disease....

Dogs fed cholestyramine had greater (P < 0.01) as-is and dry fecal output than controls. ...Future studies are required to explore

Cholestyramine for thyrotoxicosis?
Lin D, Suwantarat N, Bornemann M. Lin D, et al. J Fam Pract. 2013 Apr;62(4):E1-2. J Fam Pract. 2013. PMID: 23570035 No abstract available.
Role of Cholestyramine in Refractory Hyperthyroidism: A Case Report and Literature Review.
Alswat KA. Alswat KA. Am J Case Rep. 2015 Jul 24;16:486-90. doi: 10.12659/AJCR.893821. Am J Case Rep. 2015. PMID: 26207323 Free PMC article. Review.
Refractory hyperthyroidism is a rare condition in which hyperthyroidism fails to respond to the above therapy. Cholestyramine has been shown to decrease thyroid hormone level when added to the ongoing anti-thyroidal medications. ...The possibility of self-remission (natura …
Refractory hyperthyroidism is a rare condition in which hyperthyroidism fails to respond to the above therapy. Cholestyramine has bee …
Cholestyramine and hypercholesterolaemia.
[No authors listed] [No authors listed] Br Med J. 1968 Mar 9;1(5592):629. Br Med J. 1968. PMID: 5637576 Free PMC article. No abstract available.
Cholestyramine in dogs.
Jansen GR, Zanetti ME. Jansen GR, et al. J Pharm Sci. 1965 Jun;54(6):863-7. doi: 10.1002/jps.2600540609. J Pharm Sci. 1965. PMID: 5847019 No abstract available.
Cholestyramine in hypercholesterolaemia.
West R, Lloyd JK. West R, et al. Lancet. 1977 Feb 26;1(8009):488-9. doi: 10.1016/s0140-6736(77)91980-8. Lancet. 1977. PMID: 65596 No abstract available.
Making cholestyramine palatable.
Thompson WG. Thompson WG. Can Med Assoc J. 1971 Jun 5;104(11):986. Can Med Assoc J. 1971. PMID: 5576046 Free PMC article. No abstract available.
Cholestyramine.
[No authors listed] [No authors listed] Drug Ther Bull. 1968 Oct 11;6(21):81-2. Drug Ther Bull. 1968. PMID: 5698999 No abstract available.
3,608 results